This Week in StockHouse February 12 to 16

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

By the StockHouse Editorial Staff

This week StockHouse launched a new health sciences column (http://www.stockhouse.ca/shfn/article.asp?edtID=19325). Leon Hamerling and J. Paul reported from the BioCEO and Investor conference about an anti-cancer drug with great potential, and new drug options that could change the way heart disease is treated.

But is it time to take profits in the sector? Don Vialoux argued that health ETFs are headed lower (http://www.stockhouse.ca/shfn/editorial.asp?edtID=19331) under pressure from fundamental, seasonal and technical factors.

Given the sudden “greening” of governments everywhere, an investment in hydrogen fuel cell maker (http://www.stockhouse.ca/shfn/article.asp?edtID=19312) Plug Power (NASDAQ: PLUG) could be part of a speculative portfolio, suggested Danny Deadlock.

One of the key factors for the success of any resource junior is promotion (http://www.stockhouse.ca/shfn/article.asp?edtID=19313), because without visibility, the best deposits can go unfunded. Doug Hadfield of Resourcex Investor identified two relative unknowns that could be sitting on valuable resources.

Investors reacted very negatively when Ultra Uranium (TSX: V.ULU) released its historical resource estimate (http://www.stockhouse.ca/shfn/editorial.asp?edtID=19332) for its Slovakian property. Doug Hadfield illuminated the press release, and spoke with Anthony Beruschi, a company friend who brought the property to Ultra.

An energy exploration company (http://www.stockhouse.ca/shfn/article.asp?edtID=19323) with production in Wyoming’s Green River Basin was the feature in Micro-cap Spotlight this week.

In separate columns this week, Jon Ogg of 24/7 Wall Street gave a preview (http://www.stockhouse.ca/shfn/article.asp?edtID=19318) and review (http://www.stockhouse.ca/shfn/article.asp?edtID=19322) of the initial public offerings market.

Doug Casey thinks uranium prices still have miles to go. In an interview (http://www.stockhouse.ca/shfn/article.asp?edtID=19317) with StockHouse Publisher and Executive Editor Dain Diehl, he offered readers his eight Ps of uranium due diligence.

Steven Saville looked at the relationship (http://www.stockhouse.ca/shfn/article.asp?edtID=19324) between the U.S. dollar and gold futures prices, and noted two notable instances when the usual relationship broke down.

Mike Paulenoff urged readers to trade cautiously, as a number of technical indicators show the market may be peaking (http://www.stockhouse.ca/shfn/article.asp?edtID=19320).

Are Bombardier (TSX: T.BBD.B) shares headed for a turnaround? George Leong said technical indicators (http://www.stockhouse.ca/shfn/article.asp?edtID=19329) suggest gains may be in the offing for the transportation gear maker.

Warren Buffet is the most successful value investor, and some say, the ultimate investor. Financially Fit’s Nancy Zambell wrote about the Oracle of Omaha’s method. (http://www.stockhouse.ca/shfn/editorial.asp?edtID=19334)

Give your portfolio a workout with an Investment Policy Statement, said John De Goey. (http://www.stockhouse.ca/shfn/editorial.asp?edtID=19335).

The Top Five (http://www.stockhouse.ca/shfn/article.asp?edtID=19326) is the weekly rewind of what’s hot on StockHouse in lists.

The weekly Best of the Blogs http://www.stockhouse.ca/shfn/article.asp?edtID=19316 column by Keri Korteling featured Reminiscences of a stock blogger, a blog whose author takes a lyrical approach to resource investing.

Another trust bites the dust. The Buzz on the BullBoards (http://www.stockhouse.ca/shfn/article.asp?edtID=19330) by Sean Mason looked at investor reaction to the recent sale of a coke trust.

Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618